Roozbeh Dehghannasiri

Dr. Roozbeh Dehghannasiri

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Nature Methods
Verified
Journal Article
Closed access
PDF file
MVMarieke Vromman
Marieke Vromman
JAJasper Anckaert
Jasper Anckaert
Stefania BortoluzziStefania Bortoluzzi
Stefania Bortoluzzi
ABAlessia Buratin
Alessia Buratin
CCChia-Ying Chen
Chia-Ying Chen
Pieter-Jan VoldersPieter-Jan Volders
Pieter-Jan Volders

13 September 2021 in eLife
Verified
Journal Article
Open access
JOJulia Olivieri
Julia Olivieri
RDRoozbeh Dehghannasiri
Roozbeh Dehghannasiri
PWPeter L Wang
Peter L Wang
SJSoRi Jang
SoRi Jang
AMAntoine de Morree
Antoine de Morree
JSJulia Salzman
Julia Salzman
The extent splicing is regulated at single-cell resolution has remained controversial due to both available data and methods to interpret it. We apply the SpliZ, a new statistical approach, to detect cell-type-specific splicing in >110K cells from 12 human tissues. Using 10X Chromium data for discovery, 9.1% of genes with computable SpliZ scores are cell-type-specifically spliced, including ubiquitously expressed genes MYL6 and RPS24. These results are validated with RNA FISH, single-cell PCR, and Smart-seq2. SpliZ analysis reveals 170 genes with regulated splicing during human spermatogenesis, including examples conserved in mouse and mouse lemur. The SpliZ allows model-based identification of subpopulations indistinguishable based on gene expression, illustrated by subpopulation-specific splicing of classical monocytes involving an ultraconserved exon in SAT1. Together, this analysis of differential splicing across multiple organs establishes that splicing is regulated cell-type-specifically.

4 December 2014 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
RDRoozbeh Dehghannasiri
Roozbeh Dehghannasiri
BYByung-Jun Yoon
Byung-Jun Yoon
EDEdward R. Dougherty
Edward R. Dougherty
Of major interest to translational genomics is the intervention in gene regulatory networks (GRNs) to affect cell behavior; in particular, to alter pathological phenotypes. Owing to the complexity of GRNs, accurate network inference is practically challenging and GRN models often contain considerable amounts of uncertainty. Considering the cost and time required for conducting biological experiments, it is desirable to have a systematic method for prioritizing potential experiments so that an experiment can be chosen to optimally reduce network uncertainty. Moreover, from a translational perspective it is crucial that GRN uncertainty be quantified and reduced in a manner that pertains to the operational cost that it induces, such as the cost of network intervention. In this work, we utilize the concept of mean objective cost of uncertainty (MOCU) to propose a novel framework for optimal experimental design. In the proposed framework, potential experiments are prioritized based on the MOCU expected to remain after conducting the experiment. Based on this prioritization, one can select an optimal experiment with the largest potential to reduce the pertinent uncertainty present in the current network model. We demonstrate the effectiveness of the proposed method via extensive simulations based on synthetic and real gene regulatory networks.

1 March 2017 in Computational Materials Science
Verified
Journal Article
Closed access
RDRoozbeh Dehghannasiri
Roozbeh Dehghannasiri
Dezhen XueDezhen Xue
Dezhen Xue
PBPrasanna V. Balachandran
Prasanna V. Balachandran
MYMohammadmahdi R. Yousefi
Mohammadmahdi R. Yousefi
LDLori A. Dalton
Lori A. Dalton
EDEdward R. Dougherty
Edward R. Dougherty

10 April 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TWTimothy Ting-Hsuan Wu
Timothy Ting-Hsuan Wu
KTKyle J. Travaglini
Kyle J. Travaglini
ARArjun Rustagi
Arjun Rustagi
DXDuo Xu
Duo Xu
YZYue Zhang
Yue Zhang
MKMark A. Krasnow
Mark A. Krasnow
Early stages of deadly respiratory diseases including COVID-19 are challenging to elucidate in humans. Here, we define cellular tropism and transcriptomic effects of SARS-CoV-2 virus by productively infecting healthy human lung tissue and using scRNA-seq to reconstruct the transcriptional program in “infection pseudotime” for individual lung cell types. SARS-CoV-2 predominantly infected activated interstitial macrophages (IMs), which can accumulate thousands of viral RNA molecules, taking over 60% of the cell transcriptome and forming dense viral RNA bodies while inducing host profibrotic (TGFB1, SPP1) and inflammatory (early interferon response, CCL2/7/8/13, CXCL10, and IL6/10) programs and destroying host cell architecture. Infected alveolar macrophages (AMs) showed none of these extreme responses. Spike-dependent viral entry into AMs used ACE2 and Sialoadhesin/CD169, whereas IM entry used DC-SIGN/CD209. These results identify activated IMs as a prominent site of viral takeover, the focus of inflammation and fibrosis, and suggest targeting CD209 to prevent early pathology in COVID-19 pneumonia. This approach can be generalized to any human lung infection and to evaluate therapeutics.

23 January 2017 in IEEE Transactions on Signal Processing
Verified
Journal Article
Closed access
RDRoozbeh Dehghannasiri
Roozbeh Dehghannasiri
MEMohammad Shahrokh Esfahani
Mohammad Shahrokh Esfahani
EDEdward R. Dougherty
Edward R. Dougherty
In many contemporary engineering problems, model uncertainty is inherent because accurate system identification is virtually impossible owing to system complexity or lack of data on account of availability, time, or cost. The situation can be treated by assuming that the true model belongs to an uncertainty class of models. In this context, an intrinsically Bayesian robust (IBR) filter is one that is optimal relative to the cost function (in the classical sense) and the prior distribution over the uncertainty class (in the Bayesian sense). IBR filters have previously been found for both Wiener and granulometric morphological filtering. In this paper, we derive the IBR Kalman filter that performs optimally relative to an uncertainty class of state-space models. Introducing the notion of Bayesian innovation process and the Bayesian orthogonality principle, we show how the problem of designing an IBR Kalman filter can be reduced to a recursive system similar to the classical Kalman recursive equations, except with “effective” counterparts, such as the effective Kalman gain matrix. After deriving the recursive IBR Kalman equations for discrete time, we use the limiting method to obtain the IBR Kalman-Bucy equations for continuous time. Finally, we demonstrate the utility of the proposed framework for two real world problems: sensor networks and gene regulatory network inference.